REDWOOD CITY, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the launch of its ...
Refining the serum miR-371a-3p test for viable germ cell tumor detection: Identification and definition of an indeterminate range. Descriptive statistics summarizing the distribution of RT-qPCR (Cq) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results